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The Tobacco Products Directive allows the possibility of strategic placement of health warnings on cigarette packs
by manufacturers to reduce overall warning effectiveness. Information regarding health warning effectiveness
was assessed in an online survey, and the prevalence of warnings on cigarette packs was assessed in a shop survey.
Although we find no evidence of a strong correlation between health warning effectiveness ratings and their
frequency on cigarette packs (r=0.17, P=0.56), there may be other ways this possibility is exploited. We suggest
that this potential loophole is addressed and monitoring of the placement of health warnings on cigarette packs is
continued.
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Introduction
Cigarette pack health warnings are designed to increase healthknowledge and perceptions of risk of smoking and can
promote smoking cessation.1 The 14 pictorial warnings placed on
the back of cigarette packages in the UK between October 2008 and
May 2016 were taken from a larger set of warnings specified by the
European Commission Tobacco Products Directive (TPD; 2001/37/
EC). Article 10 of the TPD states that warnings ‘shall be rotated in
such a way as to guarantee their regular appearance’, although
‘regular’ is not defined. This offers an opportunity for tobacco
companies to strategically place health warnings on cigarette packs
in order to reduce their overall effectiveness.
Strategic placement could be achieved in a number of ways. First,
given warnings vary in their effectiveness,1,2 less effective warnings
could more frequently be placed on cigarette packs than more
effective ones. Second, warnings designed for certain target popula-
tions could be placed on packs which these populations less
frequently purchase (i.e. warnings that specifically address the
negative impacts of smoking for men could be placed more
frequently on packs more popular among women).3 While the
updated TPD (2014/40/EU), which came into force in May 2016,
provides more specific guidance on the placement of health
warnings (i.e. ‘the producer . . . must select the graphic . . . so that
each of the 14 graphics in that set appears on between 1/24 and
1/12 of the total number of packs . . .’), these regulations still allow
tobacco companies to exploit this loophole.
The primary aim of this study was to examine adherence to this TPD
requirement for the first time and explore whether there is variation in
the prevalence of certain warnings on cigarette packs. Specifically, we
aimed to address the following questions: (i) Are less effective health
warnings found more frequently on cigarette packs than more effective
health warnings? (ii) Are female-specific health warnings found less
frequently on female-specific cigarette packs than male-specific or
gender-neutral health warnings? Information regarding health-
warning effectiveness and gender specificity of warnings and cigarette
brands was assessed in an online survey and the prevalence of health
warnings on packs was assessed in a shop survey.
Methods
The protocol for both the online survey and the shop survey
was published online on the Open Science Framework prior to
testing (https://osf.io/vft3k/). The data that form the basis of
the results presented here are available from the Bristol Research
Data Repository (http://data.bris.ac.uk/data; doi: 10.5523/bris.1sx8k1da7j
fe615qyaazn3hvh0). Ethics approval was obtained from the Faculty of
Science Research Ethics Committee at the University of Bristol (ethics
approval code: 24761).
Online survey
Participants in the online survey provided demographic informa-
tion, including their smoking status, and were then shown each of
the 14 pictorial health warnings4 used in the UK (prior to May 2016)
in turn. Participants responded to two questions: (i) Whether the
warning is ‘more aimed at females’, ‘more aimed at males’ or ‘aimed
at both males and females’ and (ii) ‘Overall, on a scale from 1 to 10,
how effective is this health warning?’.5 Participants were then shown
16 cigarette packs in turn and asked to respond to a single question:
whether the pack is ‘more aimed at females’, ‘more aimed at males’
or ‘aimed at both males and females’.
Shop survey
Between July and August 2015, researchers visited shops selling
tobacco in Bristol, UK, and went behind the counter to record
the health warnings placed on the back of each of the 16 cigarette
packs assessed in the online survey. Our sample size calculation
estimated that we required 1000 cigarette packs to investigate
the relationship between warning effectiveness and frequency.
Further details are provided in the study protocol. A further 1000
female-specific cigarette packs were required to investigate the rela-
tionship between cigarette pack gender specificity and warning
frequency.
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Results
Online survey
A total of 206 participants (48.8% female) provided data, although
five participants were removed from data analysis as demographic
data were not collected. Participants had a mean age of 30.7 years
(SD 13.5). Seventy-five percent of participants were non-smokers or
ex-smokers. There was wide variation in the perceived effectiveness
scores for the warnings (figure 1). An independent samples t-test
indicated no evidence (t(110.7) = 0.77, P= 0.44) for a difference in
perceived effectiveness ratings between non-smokers (mean 5.45, SD
1.72) and smokers (mean 5.28, SD 1.30). Further analyses were
combined across smoking groups.
Four cigarette packs (all of the ‘Vogue’ brands) were identified as
being female specific (i.e. at least 70% of participants reported that
these packs were aimed at females). No packs were identified as
being male specific. Only one health warning was identified as
being female specific using this same criterion (‘Smoking when
pregnant harms your baby’). Two warnings were identified as
being male-specific (‘Smoking may reduce the blood flow and
causes impotence’ and ‘Smoking can damage the sperm and
decreases fertility’).
Shop survey
The health warnings on a total of 1,440 cigarette packs were
recorded. If the distribution of the 14 warnings was equal across
packs, we would have expected to observe 103 of each warning.
However, we observed considerable variation in health warning
prevalence. The least common warning was the ‘CHD’ warning
(figure 1), appearing on 78 packs. The most common warning was
the ‘surgery’ warning, appearing on 130 packs. However, there was
no evidence of a strong correlation between warning effectiveness
ratings and their frequency (r = 0.17, P= 0.56).
Only 29 female-specific packs were identified: 17 Vogue Bronze
(10 ‘surgery’ warnings, 7 ‘help’ warnings), 9 Vogue Menthe
(6 ‘younger’ warnings, 3 ‘surgery’ warnings), 3 Vogue Menthe
Superslim (3 ‘number’ warnings) and 0 Vogue Bleue Superslim.
Given the small sample size, statistical tests were not conducted on
these data.
Discussion
We find no evidence for a relationship between the perceived ef-
fectiveness of health warnings and their frequency on cigarette
packs. However, it is important to note that although we did
not observe evidence for these practices, they may still be
occurring. We were unable to obtain enough ‘female-specific’
cigarette packs in order to examine whether female-specific
health warnings are found less frequently on these packs than
male-specific or gender-neutral health warnings. In addition,
there may be other cigarette brands, such as those which attract
particular age groups, which may provide opportunities for
targeted health warning placement. Similarly, we were only able
to investigate if there was a relationship between health warning
effectiveness and pack frequency. There may be other warning
characteristics which tobacco companies may exploit to reduce
the overall impact of health warnings. Finally, we did not have
sufficient power to stratify our analyses by individual tobacco
companies, but it is possible that if these practices occur, they
may only occur at certain tobacco companies.
As far as we are aware, this is the first study to assess adherence to
TPD health warning regulations using this methodology, and this
proof of principle study suggests that this protocol is feasible.
Although we did not find evidence for targeted placement of
health warnings on cigarette packs, under both the 2001/37/EC
and 2014/40/EU TPDs, these practices are technically permitted.
We suggest that this potential loophole is addressed and
monitoring of the placement of health warnings on cigarette packs
is continued.
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Figure 1 Mean effectiveness scores for each of the health warnings among all participants. Error bars represent standard error of the mean
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Key points
 The Tobacco Products Directive allows the possibility of
strategic placement of health warnings on cigarette packs
by manufacturers to reduce overall warning effectiveness.
 We examined whether less effective warnings are more
frequently found on cigarette packs and whether female-
specific warnings are less frequently found on female-
specific cigarette packs.
 We did not find evidence for targeted placement of health
warnings on cigarette packs. However, there may be other
ways in which this loophole can be exploited. We suggest
that this loophole is addressed and monitoring of the
placement of health warnings on cigarette packs is
continued.
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